Pipeline
Terapias en desarollo
Nuestros equipos de investigación y desarrollo apuntan a los mecanismos subyacentes de la enfermedad cerebral. Nos movemos juntos hacia un objetivo singular para ofrecer terapias novedosas que redefinan el estándar de atención para los pacientes y aborden las áreas de enfermedad cerebral donde vemos la mayor necesidad.
| Project | Area | Phase 1 | Phase 2 | Phase 3 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Brexpiprazole | Agitation in dementia of the Alzheimer’s type | 3 | |||||||
|
Mode of Action Brexpiprazole is a molecule approved as an adjunctive therapy to antidepressants in adults with major depressive disorder (US) and as a treatment in adults with schizophrenia (US, EU, CA). Brexpiprazole is further in development for the potential treatment of agitation in dementia of the Alzheimer’s type. Find the specific study here: |
|||||||||
| Brexpiprazole | Post-Traumatic Stress Disorder | 3 | |||||||
|
Mode of Action Brexpiprazole is a molecule approved as an adjunctive therapy to antidepressants in adults with major depressive disorder (US) and as a treatment in adults with schizophrenia (US, EU, CA). Brexpiprazole is further in development for the potential treatment of agitation in dementia of the Alzheimer’s type. Find the specific study here: |
|||||||||
| Brexpiprazole | Borderline Personality Disorder | 2 | |||||||
|
Mode of Action Brexpiprazole is a molecule approved as an adjunctive therapy to antidepressants in adults with major depressive disorder (US) and as a treatment in adults with schizophrenia (US, EU, CA). Brexpiprazole is further in development for the potential treatment of agitation in dementia of the Alzheimer’s type. Find the specific study here: |
|||||||||